|
Quality
pharmaceutical products at affordable prices are
the end result of:
Product leadership, top market share maintained
by a high, reliable supplier stream and maximum
geographical distribution.
Position
& Market share
The dynamic pharmaceutical business in Yemen is requiring regular changes in the horizontal and vertical structures of the division. Hence, Al-Garash is on a constant re-engineering of its business processes and system to accommodate itself as one of the leading distributors in Yemen.
Across the market competition is increasing and declining profitability has led to Al-Garash to be proactive by re-engineering value delivery process leading to holistic marketing orientation and communicating superior customer value. This is narrowing the gap between future desired market share and projected market share.
Our partners are as follows:
Pfizer (USA)
Sanofi
aventis (France)
Jamjoom Pharma (Saudi Arabia)
Flen Pharma (Belgium)
Sanochemia (Austria)
Geopoland (Poland)
Glenmark Pharmaceuticals (India)
Orchid Pharmaceuticals (India)
Kopran Limited (India)
Intas Biopharmaceuticals (India)
Panacea Biotec (India)
Nirma –Nirlife (India)
IAristo Pharma (India)
Emcure (India)
Sirmaxo Chemical (India)
many more under registration.
Setup
and Distribution
The Pharmaceutical Industry requires an independent,
decentralized division. Our 81 professionally
skilled staff form our team of:
Senior
management
Branch
managers
Finance
managers
Accountants
Sales
manager
Medical
representatives
Sales-men
Delivery-men
Secretaries
IT
& HR officers
Public
relation officer
and
our host of store attendants
The Al-Garash Corporation understands the cost
and risk involved in transforming competitive
necessity into competitive advantage for our
Pharmaceutical Division. Therefore, operational
resources motivate an aggressive work ethic,
targeted at business development and growth:
Nationwide consumers are amply supplied through
our strong national distribution network catering maximum needs, wants and demands.
Regional branches in the cities of Sana'a, Taiz,
Aden, Hodeidah and Mukalla provide further support
for our wide distribution of pharmaceutical
dealers.
Our
main and branch offices are sufficiently equipped
to meet operational excellence while overseeing
separate supplier offices where medical representatives,
sales-men and delivery-men are well served.
And, additional facilities are continually being
created to meet the rapid growth demands of
Al-Garash's Pharmaceutical Department to better delivery and communicating superior customer value.
Prevnar Vaccine is introduced in Yemen market.
We are going to introduce cardiovascular line from Jamjoom Pharmaceuticals.
|